Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Aclarion, Inc.

Aclarion, Inc. (ACONW) Stock Overview

Explore Aclarion, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ACONW●NASDAQ
HealthcareMedical - Healthcare Information Services
$0.03
$0.005(21.95%)
U.S. Market opens in 3h 5m

Aclarion, Inc. (ACONW)

Meyka AI Score

Z

Key Financials

Market Cap16K
P/E Ratio-0.31
EPS (TTM)$-10.62
ROE-0.59%
Fundamental Analysis

AI Price Forecasts

1 Month$0.04
3 Months$0.04
1 Year Target$0.02

ACONW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Aclarion, Inc. (NASDAQ: ACONW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Aclarion, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ACONW on the NASDAQ shows an RSI of 56.27, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.02 for the NASDAQ listing.

Key metrics behind Aclarion, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.31 and a market capitalization of 16K. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACONW on the NASDAQ.

Price Performance (NASDAQ: ACONW)

1-Day Change
21.95%
5-Day Change
N/A
1-Month Change
23.97%
3-Month Change
-7.55%
6-Month Change
-11.76%
Year-to-Date (YTD) Change
-20.84%
1-Year Change
-34.64%
3-Year Change
-50.00%
5-Year Change
-95.90%
All-Time (Max) Change
-95.90%

Contact Information

https://www.aclarion.com
650-241-1741
8181 Arista Place, Broomfield, CA, 80021

Company Facts

110 Employees
IPO DateApr 22, 2022
CountryUS
Actively Trading

Frequently Asked Questions